Dermatitis herpetiformis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
Jun 2023Dermatitis Herpetiformis Refractory to Gluten Free Diet

Tampere University Hospital

TrialENROLLING BY INVITATION
Nov 2022Background of Different Phenotypes of Coeliac Disease

Tampere University Hospital

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Dermatitis herpetiformis.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Dyural 80-Lm

(METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL)Orphan drugstandard

Advanced Rx Pharmacy of Tennessee, LLC

12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

2 active trials
2Unknown
2Total recruiting
Search clinical trials for Dermatitis herpetiformis

Recent News & Research

No recent news articles indexed yet for Dermatitis herpetiformis.
Search PubMed for Dermatitis herpetiformis

Browse all Dermatitis herpetiformis news →

Specialist Network

Top 6 by expertise

View all Dermatitis herpetiformis specialists →

Quick Actions